Hi, this is Rajiv Rawal. I'm the Global Director of Software, Life Sciences Mass Spectrometry, Thermo
Fisher Scientific. So we have a lot
of excitement in a lot of areas.
We're producing new software for our Metabolomics
market space, Compound Discoverer 2.0,
in which we can now ID untargeted
discovery.
We have for the biopharma market, we
have a new characterization piece of software which
we are very excited about and then as you can see in this area that we have our Cloud-based
Applications.
So we have a couple of areas that we're
really concentrating on. One is
on our project how to take our multi-omics data and actually create
biological information out of that and
then
the other side is actually, we have software to now monitor your instruments.
Literally we can do that in an iPad or
an iPhone or you could
see it remotely wherever you are, how your instruments are performing,
if they have any error statistics
around that area or if you want to be notified
through email
there's, you know, on sequence completion, 
batch completion, those kind of things and
then we have an entire data processing
work flow as well which we call our
Sample Profiler. So this is to really do
more things like,
What is normal in my sample?
So it compares your data to see what are
the emerging contaminants or,
or you could do QC diagnostics and that
how's your instrument perfoming if you
want to shoot some standards and see
how those standards are behaving relative to the performance that you
would expect.
So we have the entire workflow where you can do and then you can do
Big Data mining out of that and see how
all the normals that you have accumulated
over time,
you know, whether a sample is
within range or not.
And so these are just some
of the seeds that we're planning but
we're very, very excited about some of
softwares that we're going to be
releasing very soon in the Cloud
area.
